Long-term efficacy and safety of bimatoprost for intraocular pressure lowering in glaucoma and ocular hypertension: year 4.

Abstract

BACKGROUND Bimatoprost 0.03% has been shown to consistently reduce mean intraocular pressure (IOP) more than timolol 0.5% over 2 years. To further evaluate long-term safety and efficacy, once-daily bimatoprost 0.03% was compared with timolol 0.5% twice daily through year 4. METHODS In this multicentre, double-masked, randomised, controlled trial, glaucoma… (More)
DOI: 10.1136/bjo.2007.128454

Topics

Cite this paper

@article{Williams2008LongtermEA, title={Long-term efficacy and safety of bimatoprost for intraocular pressure lowering in glaucoma and ocular hypertension: year 4.}, author={R. D. Williams and Judith Cohen and Roland Gross and C-C. Liu and Eric L Safyan and Amy L Batoosingh}, journal={The British journal of ophthalmology}, year={2008}, volume={92 10}, pages={1387-92} }